Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 6,318 | 1,982 | 3,852 | 3,378 | 2,817 |
| Cost of Goods | 344 | 168 | 235 | 247 | 150 |
| Gross Profit | 5,974 | 1,814 | 3,617 | 3,131 | 2,667 |
| Operating Expenses | 2,527 | 2,805 | 2,966 | 2,683 | 3,187 |
| Operating Income | 3,791 | -823 | 886 | 695 | -370 |
| Interest Expense | 1,596 | 2,126 | 2,269 | 1,931 | 1,678 |
| Other Income | -857 | -382 | -552 | -261 | 323 |
| Pre-tax Income | 1,338 | -3,331 | -1,935 | -1,497 | -1,725 |
| Income Tax | -1 | 4 | 16 | 579 | -590 |
| Net Income Continuous | 1,339 | -3,335 | -1,951 | -2,076 | -1,135 |
| Net Income | $1,339 | $-3,335 | $-1,951 | $-2,076 | $-1,135 |
| EPS Basic Total Ops | 0.02 | -0.05 | -0.03 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | 0.02 | -0.05 | -0.03 | -0.03 | -0.02 |
| EPS Diluted Total Ops | 0.02 | -0.05 | -0.03 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | 0.01 | -0.05 | -0.03 | -0.03 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.02 | -0.05 | -0.03 | -0.03 | -0.02 |
| EBITDA(a) | $3,919 | $-644 | $1,092 | $852 | $-238 |